Author

Mara Couto-Rodriguez

ORCID 0000-0002-9799-0068Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:machine learning (classical)· 2 Research Focus:variant calling· 2 Assay:bulk RNA-seq· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Christopher E. MasoniD· 3 shared David DankoiD· 3 shared Dorottya Nagy‐SzakaliD· 3 shared Heather WellsiD· 3 shared Niamh B. O’HaraiD· 3 shared Gábor Fidler· 2 shared John C Papciak· 2 shared Lorenzo Uccellini· 2 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Christopher E. MasonORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BIOTIA-DX RESISTANCE Achieved the Best Antimicrobial Resistance Phenotype Prediction Accuracy at CAMDA 2026

Gábor Fidler, Heather Wells, Patrick Ford Combs, John C Papciak, Mara Couto-Rodriguez, Sol Rey, Tiara Rivera, Lorenzo Uccellini, Christopher E. Mason, Niamh B. O’Hara, Dorottya Nagy‐Szakal, David Danko

The paper introduces BDXR, a method for antimicrobial resistance prediction, achieving high accuracy across six species-drug pairs in the CAMDA 2026 challenge.

bioRxiv · May 13, 2026 · PreprintMicrobiology

BIOTIA-DX RESISTANCE Achieved the Best Antimicrobial Resistance Phenotype Prediction Accuracy at CAMDA 2025

The paper introduces BDXR, a tool for predicting antimicrobial resistance from whole genome sequencing, achieving high accuracy in the CAMDA 2025 challenge.

bioRxiv · Sep 24, 2025 · PreprintMicrobiology

Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions

Daniel Butler, Christopher Mozsary, Cem Meydan, Jonathan Foox, Joel A. Rosiene, Alon Shaiber, David Danko, Ebrahim Afshinnekoo, Matthew J. MacKay, Fritz Joachim Sedlazeck, Nikolay A. Ivanov, Maria A. Sierra, Diana Pohle, Michael Zietz, Undina Gisladottir, , Christopher E. Mason

This study uses rapid diagnostics and metatranscriptomics to analyze SARS-CoV-2 infection, revealing viral evolution, host responses, and drug interactions in NYC samples.

Nature Communications · Mar 12, 2021Peer-reviewedMolecular Biology